On the other hand, TGFβ treatment increased FN1 protein levels in CON (1.7-fold) and IPF (1.3-fold) cells, an effect that was statistically significant (p < 0.01). This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.